New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- 4 January 2012
- journal article
- review article
- Published by Informa UK Limited in Expert Opinion on Investigational Drugs
- Vol. 21 (2), 153-168
- https://doi.org/10.1517/13543784.2012.651457
Abstract
(2012). New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors. Expert Opinion on Investigational Drugs: Vol. 21, No. 2, pp. 153-168.Keywords
This publication has 115 references indexed in Scilit:
- Therapies for dopaminergic‐induced dyskinesias in parkinson diseaseAnnals of Neurology, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian miceProceedings of the National Academy of Sciences, 2010
- Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesiasNeuroscience, 2010
- Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned ratsNeuroscience, 2009
- Pharmacological Modulation of Glutamate Transmission in a Rat Model of l-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear SignalingJournal of Pharmacology and Experimental Therapeutics, 2009
- Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonismMovement Disorders, 2008
- Dopamine depletion and subsequent treatment with l‐DOPA, but not the long‐lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatumJournal of Neurochemistry, 2007
- Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidinesBioorganic & Medicinal Chemistry Letters, 2007
- Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesiaNature Neuroscience, 2003